Salternamides A-D from a Halophilic Streptomyces sp. Actinobacterium

Area of Science:

• Marine natural products chemistry
• Microbial secondary metabolism
• Drug discovery

Background:

• Actinomycetes from marine salterns are a source of novel bioactive compounds.
• The manumycin family is known for its diverse biological activities.
• Understanding new metabolites from unexplored environments is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize new secondary metabolites from a halophilic Streptomyces strain.
• To investigate the structural features and absolute configurations of these novel compounds.
• To evaluate the cytotoxic and enzyme inhibitory activities of the isolated metabolites.

Main Methods:

• Isolation of halophilic Streptomyces from a marine saltern.
• Structure elucidation using comprehensive spectroscopic analyses (NMR, MS).
• Determination of absolute configurations via modified Mosher's method, J-based analysis, and CD spectroscopy.
• In vitro cytotoxicity assays against human cancer cell lines (HCT116, SNU638).
• Enzyme inhibition assays for Na+/K+ ATPase activity.

Main Results:

• Four new manumycin derivatives, salternamides A-D, were identified.
• Salternamide A is the first chlorinated manumycin derivative reported.
• Salternamide A demonstrated significant cytotoxicity against HCT116 and SNU638 cells (submicromolar IC50).
• Salternamides A and D exhibited weak inhibition of Na+/K+ ATPase.

Conclusions:

• Salternamides A-D represent a new class of manumycin antibiotics from marine salterns.
• Salternamide A possesses potent anticancer properties, warranting further investigation.
• The findings highlight the potential of saltern-derived actinomycetes as a source of novel therapeutic agents.